Market Cap 31.67M
Revenue (ttm) 1.63M
Net Income (ttm) -18.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,154.60%
Debt to Equity Ratio 0.02
Volume 305,454
Avg Vol 1,093,850
Day's Range N/A - N/A
Shares Out 58.48M
Stochastic %K 89%
Beta -2.54
Analysts Strong Sell
Price Target $4.50

Company Profile

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-genera...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 770 500 3910
Fax: 404 581 5903
Address:
3950 Johns Creek Court, Suite 100, Suwanee, United States
TripTrap
TripTrap Feb. 23 at 5:14 PM
$FEMY Really? Is that because you haven’t bothered to do any research, you timed your trade wrong, have no patience and it’s time to change your diaper? Bullish AF!!
1 · Reply
Ked1977
Ked1977 Feb. 23 at 5:08 PM
$FEMY Femasys announced that the AMA approved a new Category III CPT code for its FemaSeed procedure. While this is technically positive news, the stock went down because investors didn’t see it as an immediate financial benefit. The new CPT code does not go into effect until January 1, 2027, which means it will not generate revenue in the near term. In addition, Category III codes are temporary tracking codes and do not guarantee insurance reimbursement. That means payment rates still need to be determined later, and widespread adoption is not assured. Because the announcement was more of a long-term reimbursement step rather than a near-term revenue driver, traders likely viewed it as a procedural milestone rather than a catalyst that would immediately improve earnings. As a result, many investors “sold the news,” leading to the stock declining despite the positive headline.
0 · Reply
Five555
Five555 Feb. 23 at 4:56 PM
$FEMY is a pos
1 · Reply
TripTrap
TripTrap Feb. 23 at 3:08 PM
$FEMY This is bigger news than most people realize… And certainly bigger news than the market is giving it credit for. This removes the biggest barrier to FemaSeed adoption - cost. When insurance starts covering it, utilization should accelerate dramatically. Combined with the FemSperm rollout to gynecologists, this sets up 2027 to be a breakout year for FemaSeed commercialization….unfortunately, we still just need to hurry up and wait. This is a perfect time to continue to accumulate an endure the comments of people that haven’t bothered to do their research.
0 · Reply
steve04240
steve04240 Feb. 23 at 3:01 PM
$FEMY yet another step in the process....
0 · Reply
steve04240
steve04240 Feb. 23 at 2:25 PM
0 · Reply
beart00th
beart00th Feb. 23 at 2:20 PM
$FEMY https://ir.femasys.com/news/news-details/2026/Femasys-Receives-AMA-CPT-Editorial-Panel-Approval-for-New-Category-III-CPT-Code-for-FemaSeed-Intratubal-Insemination/default.aspx
0 · Reply
beart00th
beart00th Feb. 23 at 2:10 PM
$FEMY news. CPT Code Reimbursement specifically for femaseed ITI
0 · Reply
beart00th
beart00th Feb. 21 at 3:30 PM
$FEMY another fertility clinic is adopting ITI. Just found this scrolling. https://blueskyfertility.com/blue-sky-fertility-welcomes-new-fertility-treatment/
3 · Reply
4RiskyBusiness4
4RiskyBusiness4 Feb. 21 at 2:42 PM
$FEMY Strong move ahead.
0 · Reply
Latest News on FEMY
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Oct 16, 2025, 9:00 AM EDT - 4 months ago

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo


Femasys Announces Second Quarter Financial Results for 2025

Aug 8, 2025, 4:05 PM EDT - 7 months ago

Femasys Announces Second Quarter Financial Results for 2025


TripTrap
TripTrap Feb. 23 at 5:14 PM
$FEMY Really? Is that because you haven’t bothered to do any research, you timed your trade wrong, have no patience and it’s time to change your diaper? Bullish AF!!
1 · Reply
Ked1977
Ked1977 Feb. 23 at 5:08 PM
$FEMY Femasys announced that the AMA approved a new Category III CPT code for its FemaSeed procedure. While this is technically positive news, the stock went down because investors didn’t see it as an immediate financial benefit. The new CPT code does not go into effect until January 1, 2027, which means it will not generate revenue in the near term. In addition, Category III codes are temporary tracking codes and do not guarantee insurance reimbursement. That means payment rates still need to be determined later, and widespread adoption is not assured. Because the announcement was more of a long-term reimbursement step rather than a near-term revenue driver, traders likely viewed it as a procedural milestone rather than a catalyst that would immediately improve earnings. As a result, many investors “sold the news,” leading to the stock declining despite the positive headline.
0 · Reply
Five555
Five555 Feb. 23 at 4:56 PM
$FEMY is a pos
1 · Reply
TripTrap
TripTrap Feb. 23 at 3:08 PM
$FEMY This is bigger news than most people realize… And certainly bigger news than the market is giving it credit for. This removes the biggest barrier to FemaSeed adoption - cost. When insurance starts covering it, utilization should accelerate dramatically. Combined with the FemSperm rollout to gynecologists, this sets up 2027 to be a breakout year for FemaSeed commercialization….unfortunately, we still just need to hurry up and wait. This is a perfect time to continue to accumulate an endure the comments of people that haven’t bothered to do their research.
0 · Reply
steve04240
steve04240 Feb. 23 at 3:01 PM
$FEMY yet another step in the process....
0 · Reply
steve04240
steve04240 Feb. 23 at 2:25 PM
0 · Reply
beart00th
beart00th Feb. 23 at 2:20 PM
$FEMY https://ir.femasys.com/news/news-details/2026/Femasys-Receives-AMA-CPT-Editorial-Panel-Approval-for-New-Category-III-CPT-Code-for-FemaSeed-Intratubal-Insemination/default.aspx
0 · Reply
beart00th
beart00th Feb. 23 at 2:10 PM
$FEMY news. CPT Code Reimbursement specifically for femaseed ITI
0 · Reply
beart00th
beart00th Feb. 21 at 3:30 PM
$FEMY another fertility clinic is adopting ITI. Just found this scrolling. https://blueskyfertility.com/blue-sky-fertility-welcomes-new-fertility-treatment/
3 · Reply
4RiskyBusiness4
4RiskyBusiness4 Feb. 21 at 2:42 PM
$FEMY Strong move ahead.
0 · Reply
TripTrap
TripTrap Feb. 21 at 2:20 PM
$FEMY BREAKING News!!! Just saw Form 4s drop yesterday… MASSIVE equity grants to management: -CEO Kathy Lee-Sepsick: 729,000 RSUs -CFO Dov Elefant: 342,000 RSUs -New CTO Jeremy Sipos: 80,000 RSUs (from last week) TOTAL: 1.15 MILLION RSUs granted to management! Here’s why this kicks ass: -Zero cash burned - all equity compensation -Ultimate skin in game - they only win if we win -Retention through FDA trial - management locked in for critical period -Confidence signal - you don’t grant this much equity unless you expect major appreciation At current $0.54, these RSUs represent ~$621K in TODAY’S value. But their actual worth depends entirely on future stock performance: A $2.00 stock = $2.3 MILLION in management compensation. A $5.00 stock = $5.75 MILLION, and a $10.00 stock = $11.5 MILLION It’s like giving themselves winning lottery tickets, but they can only cash in if price explodes… Why would they do this? Think about it…💪💪
1 · Reply
TripTrap
TripTrap Feb. 21 at 12:37 AM
$FEMY Wrong Mirto. Sipos gets 80K RSUs (restricted stock units), not cash….RSUs cost the company ZERO dollars - they’re just future shares if he stays employed and vests over 4 years. This is actually brilliant cash management. They’re attracting a CTO through equity alignment rather than burning precious cash on salary. His success depends entirely on stock recovery. Most of his existing options are underwater ($0.80-$6.12 strikes vs $0.54 stock). He only wins if shareholders win!!! Bullish AF!!! 🔥🔥
1 · Reply
TripTrap
TripTrap Feb. 21 at 12:25 AM
$FEMY $FEMY Yes Mirto… that’s why multiple institutions bought in recently. Just so they can throw their money away. I doubt you even know what a 13F filing is… When this thing finally takes off, believe me, I’ll call you out front and center .
0 · Reply
Mirto
Mirto Feb. 20 at 7:50 PM
$FEMY great week. Market says: Thanks Kathy Septic for bringing on another worthless do nothing high salaried pig. Cash will run out quicker and fast forward the RS to achieve compliance. Fing joke.
0 · Reply
JohnnyUtah309
JohnnyUtah309 Feb. 20 at 7:34 PM
0 · Reply
TripTrap
TripTrap Feb. 20 at 5:44 PM
$FEMY Intra-day price action is chomping at the bit, wanting to break out to the upside. The only question is, will it do it this afternoon or will it wait for Monday? Bullish AF!!
0 · Reply
Alican1994
Alican1994 Feb. 20 at 3:43 PM
$FEMY No negative and freaking shorty allowed
0 · Reply
steve04240
steve04240 Feb. 20 at 12:14 PM
$FEMY Good things on the horizon
0 · Reply
TripTrap
TripTrap Feb. 19 at 9:09 PM
$FEMY Nice close at the highs. Setting up for a gap up on the open over some news tomorrow morning? Maybe - Friday is a good day for that kind thing… We’ll see. 
0 · Reply
steve04240
steve04240 Feb. 19 at 11:44 AM
$FEMY setting up for a good day?
1 · Reply
Trissy08
Trissy08 Feb. 18 at 9:38 PM
$FEMY wow. Just gave up all the hard earned Ed gains of past 2 days. Frustrating
2 · Reply
TripTrap
TripTrap Feb. 18 at 5:49 PM
$FEMY Holy crap - look what I just found in yesterday's 13F filings!!! Do you want the bad news or the good news first? Let's start with the bad news: SOLD (December 31st): -SUSQUEHANNA: -31,646 shares -TOWER RESEARCH: -17,713 shares -XTX TOPCO: -22,070 shares Now the GOOD news- 7 Institutions bought: -DAUNTLESS INVESTMENT: +4,199,347 shares (ADDING to position!) -CITADEL ADVISORS: +342,166 shares (NEW position!) -CETERA INVESTMENT: +62,000 shares (NEW!) -KOVACK ADVISORS: +46,800 shares (NEW!) -TWO SIGMA SECURITIES: +31,163 shares (NEW!) -TWO SIGMA INVESTMENTS: +26,141 shares (NEW!) -FMR LLC (Fidelity): +7,500 shares (NEW!) The Math: Total Bought: 4,729,117 shares Total Sold: 71,429 shares Net institutional buying = 4.66 MILLION shares on 12/31/25! 6 of these are BRAND NEW positions. Only Dauntless was adding to existing holdings. These institutions bought the December tax-loss dip while retail panicked! Hell yeah...LFG!!!🔥🔥
0 · Reply